Improving clinical descriptions to understand the effects of dementia treatment: consensus recommendations.
about
Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.Global assessment measures for assessing efficacy in dementia drug trials.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.Should we listen to people affected by dementia?Physicians' efficacy requirements for prescribing medications to persons with Alzheimer's disease.
P2860
Improving clinical descriptions to understand the effects of dementia treatment: consensus recommendations.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Improving clinical description ...... nt: consensus recommendations.
@ast
Improving clinical description ...... nt: consensus recommendations.
@en
Improving clinical description ...... nt: consensus recommendations.
@nl
type
label
Improving clinical description ...... nt: consensus recommendations.
@ast
Improving clinical description ...... nt: consensus recommendations.
@en
Improving clinical description ...... nt: consensus recommendations.
@nl
prefLabel
Improving clinical description ...... nt: consensus recommendations.
@ast
Improving clinical description ...... nt: consensus recommendations.
@en
Improving clinical description ...... nt: consensus recommendations.
@nl
P2093
P2860
P356
P1476
Improving clinical description ...... nt: consensus recommendations.
@en
P2093
Christine Joffres
Halifax Consensus Conference on Understanding the Effects of Dementia Treatment
Kenneth Rockwood
P2860
P304
P356
10.1002/GPS.733
P407
P577
2002-11-01T00:00:00Z